aid: evergreen-theragnostics
name: Evergreen Theragnostics
description: 'Evergreen Theragnostics is a Springfield, New Jersey radiopharmaceutical company
  founded in 2019 that operates a cGMP contract development and manufacturing organization
  (CDMO) for therapeutic and diagnostic radiopharmaceuticals, alongside its own clinical
  pipeline of theragnostic pairs including the OCTEVY PET diagnostic imaging agent for
  neuroendocrine tumors. Its 14,000 square foot Springfield facility carries seven commercial-scale
  production suites, sterility lines, quality control and packaging space serving radioligand
  therapy developers. Lantheus Holdings completed its acquisition of the company on April 1,
  2025, and Evergreen now operates as part of Lantheus. The company sells manufacturing
  services and drug products, not software: it publishes no developer program, no public API,
  and no machine-readable specifications.'
image: https://www.evergreentgn.com/wp-content/uploads/evergreen-theragnostics-og-img.jpg
url: https://raw.githubusercontent.com/api-evangelist/evergreen-theragnostics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Health Care
- Pharmaceuticals
- Life Sciences
- Manufacturing
- Radiopharmaceuticals
- Oncology
- Contract Manufacturing
- Medical Imaging
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evergreen-theragnostics-domain-security.yml
- type: Website
  url: https://www.evergreentgn.com/
- type: About
  url: https://www.evergreentgn.com/about-us/
- type: Blog
  url: https://www.evergreentgn.com/news/
- type: BlogRSS
  url: https://www.evergreentgn.com/feed/
- type: PrivacyPolicy
  url: https://www.evergreentgn.com/privacy-policy
- type: TermsOfService
  url: https://www.evergreentgn.com/terms-of-use
- type: LinkedIn
  url: https://www.linkedin.com/company/evergreentgn
- type: SecondaryMarket
  url: https://forgeglobal.com/evergreen-theragnostics_stock/
x-acquired-by:
  company: Lantheus Holdings, Inc.
  date: '2025-04-01'
  source: https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-completes-acquisition-evergreen-theragnostics
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Evergreen Theragnostics is a cGMP radiopharmaceutical CDMO and drug developer whose
    product is manufactured radioligand doses, not software — its six-page WordPress
    marketing site has no developer, docs, or api subdomain (all three fail to resolve in
    DNS), no GitHub organization, and every /.well-known/ path returns the theme 404 page.
  evidence:
  - url: https://www.evergreentgn.com/.well-known/agent-card.json
    status: 404
  - url: https://www.evergreentgn.com/openapi.json
    status: 404
  - url: https://www.evergreentgn.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/evergreentgn
    status: 404
  checked: '2026-08-12'